WoundReference improves clinical decisions
 Choose the role that best describes you
Lohiya A Jr, Dhaniwala N, Dudhekar U, Goyal S, Patel SK, et al.
Cureus. Date of publication 2023 Dec 14;volume 15(12):e50510.
1. Cureus. 2023 Dec 14;15(12):e50510. doi: 10.7759/cureus.50510. eCollection 2023 Dec. A Comprehensive Review of Treatment Strategies for Early Avascular Necrosis. Lohiya A Jr(1), Dhaniwala N(2), Dudhekar U(2), Goyal S(2), Patel SK(3). Author information: (1)Department of Orthopaedics and Traumatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND. (2)Department of Orthopaedic Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND. (3)Department of Orthopaedics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND. Avascular necrosis (AVN), characterised by compromised blood supply leading to bone necrosis, poses a significant challenge in orthopaedic and rheumatologic practice. This review comprehensively examines early AVN treatment strategies, including aetiology and risk factors, clinical presentation, conservative and surgical approaches, emerging therapies, and rehabilitation. Key findings underscore the importance of early detection, personalised treatment plans, and a multidisciplinary approach involving orthopaedic specialists, rheumatologists, and physical therapists. The implications for clinical practice emphasise individualised care, staying abreast of emerging therapies, and patient education. Recommendations for future management strategies highlight the need for imaging technology advancements, regenerative therapies integration, and ongoing research into genetic and molecular pathways. As the field continues to evolve, translating research findings into clinical practice holds promise for improving outcomes and enhancing the overall quality of life for individuals affected by AVN. Copyright © 2023, Lohiya et al. DOI: 10.7759/cureus.50510 PMCID: PMC10788237 PMID: 38226130 Conflict of interest statement: The authors have declared that no competing interests exist.
Appears in following Topics:
Avascular Necrosis (Aseptic Osteonecrosis)
t
-->